InVivo Therapeutics Holdings Corp. (NVIV) financial statements (2022 and earlier)

Company profile

Business Address ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,03121,10123,02424,76719,4937,9019,825
Cash and cash equivalents19,03121,10123,02424,76719,4937,9019,825
Restricted cash and investments      6
Other undisclosed current assets111290531751163283508
Total current assets:19,14221,39123,55525,51819,6568,18410,339
Noncurrent Assets
Operating lease, right-of-use asset1,2298339198539281,0001,072
Property, plant and equipment127776876858382
Prepaid expense1,1221,1221,1221,1221,1221,1221,122
Restricted cash and investments150150150110110110110
Other noncurrent assets   491317
Total noncurrent assets:2,6282,1822,2592,1652,2542,3282,403
TOTAL ASSETS:21,77023,57325,81427,68321,91010,51212,742
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,2511,6261,4231,1391,6451,5491,482
Accounts payable605511610640481587518
Accrued liabilities1,6461,1158134991,164962964
Other undisclosed current liabilities361384375336327318310
Total current liabilities:2,6122,0101,7981,4751,9721,8671,792
Noncurrent Liabilities
Long-term debt and lease obligation949530629605693779861
Operating lease, liability949530629605693779861
Liabilities, other than long-term debt94897779595959
Other liabilities94897779595959
Total noncurrent liabilities:1,043619706684752838920
Total liabilities:3,6552,6292,5042,1592,7242,7052,712
Stockholders' equity
Stockholders' equity attributable to parent18,11520,94423,31025,52419,1867,80710,030
Common stock3333322
Additional paid in capital256,241256,158256,073255,978247,417233,847233,791
Accumulated deficit(238,129)(235,217)(232,766)(230,457)(228,234)(226,042)(223,763)
Total stockholders' equity:18,11520,94423,31025,52419,1867,80710,030
TOTAL LIABILITIES AND EQUITY:21,77023,57325,81427,68321,91010,51212,742

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Operating expenses(2,913)(2,453)(2,310)(2,224)(2,191)(2,283)(2,195)
Operating loss:(2,913)(2,453)(2,310)(2,224)(2,191)(2,283)(2,195)
Nonoperating income (expense)1211(1)46
Other nonoperating income11   22
Net loss available to common stockholders, diluted:(2,912)(2,451)(2,309)(2,223)(2,192)(2,279)(2,189)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(2,912)(2,451)(2,309)(2,223)(2,192)(2,279)(2,189)
Comprehensive loss, net of tax, attributable to parent:(2,912)(2,451)(2,309)(2,223)(2,192)(2,279)(2,189)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: